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Magnetic nanoparticles for Bio-analytical Applications 
Sri Lakshmi Yedlapalli 
 
Magnetic nanoparticles are widely being used in various fields of medicine, 
biology and separations. This dissertation focuses on the synthesis and use of 
magnetic nanoparticles for targeted drug delivery and analytical separations. The 
goals of this research include synthesis of biocompatible surface modified 
monodisperse superparamagnetic iron oxide nanoparticles (SPIONs) by novel 
techniques for targeted drug delivery and use of SPIONs as analytical sensing 
tools. Surface modification of SPIONs was performed with two different co-
polymers: tri block copolymer Pluronics and octylamine modified polyacrylic acid. 
 
Samples of SPIONs were subsequently modified with 4 different commercially 
available, FDA approved tri-block copolymers (Pluronics), covering a wide range 
of molecular weights (5.75-14.6 kDa). A novel, technically simpler and faster 
phase transfer approach was developed to surface modify the SPIONs with 
Pluronics for drug delivery and other biomedical applications. The hydrodynamic 
diameter and aggregation properties of the Pluronic modified SPIONs were 
studied by dynamic light scattering (DLS). The coverage of SPIONs with 
Pluronics was supported with IR Spectroscopy and characterized by Thermo 
gravimetric Analysis (TGA). The drug entrapment capacity of SPIONs was 
studied by UV-VIS spectroscopy using a hydrophobic carbocyanine dye, which 
serves as a model for hydrophobic drugs. These studies resulted in a 
comparison of physical properties and their implications for drug loading 
capacities of the four types of Pluronic coated SPIONs for drug delivery 
assessment. These drug delivery systems could be used for passive drug 
targeting. However, Pluronics lack the functional group necessary for 
bioconjugation and hence cannot achieve active targeting. 
 
 
SPIONs were functionalized with octylamine modified polyacrylic acid-based 
copolymer, providing water solubility and facile biomolecular conjugation. 
Epirubicin was loaded onto SPIONs and the drug entrapment was studied by UV-
VIS spectrophotometry. In this study, the antisense oligonucleotide sequence to 
the anti-apoptopic protein survivin was coupled to SPIONs to provide molecular 
targeting and potential therapy for cancer cells. Successful coupling of antisense 
survivin to SPIONs was demonstrated by circular dichroism studies of the 
conjugate and its complementary sequence. Such multifunctional SPIONs can be 
used as active targeting agents for cancer cells, producing enhanced magnetic 
resonance imaging contrast and releasing chemotherapeutic agents to targeted 
cells. 
 
SPIONs also serve as an excellent platform for analytical sensing. Streptavidin 
modified SPIONs were used as substrates to immobilize biotinylated aptamers 
(single-stranded DNA). The binding affinity of such aptamers to its target was 
achieved by quantifying the amount of target released from the aptamer. This 
quantification was achieved using pH-mediated stacking capillary 
electrophoresis. SPIONs were shown to be more efficient compared to magnetic 
microbeads as the sensing elements. The binding affinity constant of the aptamer 
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Chapter 1  2
 
Nanoparticles, due to their size, offer a number of special optical1, electronic2 
properties. The physico-chemical properties of nanoparticles differ vastly 
depending on their dimensions, charge, hydrophobicity and the surface coating. 
Magnetic nanoparticles have an additional property of responding to magnetic 
field.3 
 
Magnetic particles ranging from nanometer (nm) to micrometer (um) size are 
widely being used in the various fields such as sensing, diagnostics and drug 
delivery.4, 5 Successful application of the nanoparticles in these areas is highly 
dependent on the stability of these particles under different aqueous and 
physiological conditions. The ability to solubilize the nanoparticles in water and to 
modify their surface with molecules, proteins or other targeting agents is a crucial 
step for their biomedical applications and bioanalysis.6 
 
In the last two decades, the use of magnetic nanoparticles in biomedical 
applications has been increasing, especially in the treatment of cancer through 
tumor targeting. Though there are different ways to treat cancer, such as surgery, 
radiation, chemotherapy etc., the most widely used approach is chemotherapy, 
but there are a number of limitations with conventional chemotherapeutic 
approaches. The major disadvantage in conventional chemotherapeutic 
approaches for cancer treatment is non-specificity that results in undesirable side 
effects.7 The use of nanoparticles as drug delivery vectors can revolutionize 
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cancer therapy. Magnetic nanoparticles can be used to target specific site of 
cancer. As nanoparticles are very small, they are easily accepted by cells, and 
hence many small molecules, nucleic acids, peptides are being loaded into 
nanoparticles and targeted to the specific tissues. SPIONs are FDA approved 
and are being used in clinical applications.8 
 
Using nanoparticles in drug delivery reduces the drug dose and improves drug 
efficiency. Since most normal tissues have non-leaky microvasculature, long 
circulating nanoparticles accumulate to a greater extent in the leaky tumor tissue 
with poor lymphatic drainage system. This passive targeting of the drug is 
achieved by enhanced permeability and retention effect. Prolonged circulation of 
the drug results in better targeting efficiency due to greater accumulation of drug 




Figure 1-1: Accumulation of nanoparticles by Enhanced permeability and 
retention effect [Passive targeting] 
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Iron Oxide is the most commonly used metal in nanoparticle formulations. Two 
types of Iron oxides have been investigated for use in magnetic nanoparticle 
formulations: Maghemite [γ-Fe2O3] and Magnetite [Fe3O4]. Magnetic 
nanoparticles are potentially used in biomedical applications due to their high 
stability and non-toxic nature.6 
 
Depending on the size of the magnetic nanoparticles, they are named as 
superparamagnetic iron oxide nanoparticles (SPIONs).  A superparamagnetic 
material is composed of small ferromagnetic crystallites which randomly flip their 
magnetic moment direction under thermal fluctuations. As a result, the material 
as a whole is not magnetized except in an externally applied magnetic field 
(similar to paramagnetic material). Due to this magnetic nature, SPIONs can be 
used as site specific release drug carriers, magnetic resonance imaging (MRI) 
agents and in hyperthermia. SPIONs with core sizes ranging from 3 to 10 nm 
with dextran polymer coating are approved for use as MRI contrast agents in 
patients. Commercially available iron oxide formulations for MRI include Ferridex, 
Combidex and Sinerem.10 
 
1.3 Synthesis of magnetic iron oxide nanoparticles 
Iron Oxide Nanoparticles were produced by many different methods. These 
include co-precipitation, thermal decomposition, microemulsion and hydrothermal 
synthesis11. However, thermal decomposition is preferred in terms of size and 
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morphology control of nanoparticles.12  Table-1 shows the summary comparison 













Co-precipitation Very simple, 
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1.2 Surface modifications on magnetic nanoparticles 
Size and surface characteristics are two important parameters which highly 
dictate particle stability and interactions of the particles with biological 
environment. To make these nanoparticles biocompatible and attach 
biomolecules, they must undergo surface modifications.4, 13 Magnetic 
nanoparticles have been surface modified with different polymers such as 
polyethylene glycol (PEG), polyacrylic acid (PAA), polyvinyl alcohol (PVA), 
dextran etc.  Alteration of the surface chemistry and physical properties enables 
in preparation of functional magnetic nanoparticles apart from providing 
increased stability. Stabilization of nanoparticles by surfactants or polymers can 
be due to electrostatic repulsion of surface charges or steric stabilization. 
Polymers can attach to nanoparticles by physical adsorption due to weak Vander 
Waals forces, dipole-dipole interactions or hydrogen bonds and chemical 
adsorption by electrostatic or covalent bonds. Surface modified nanoparticles 
also help in coupling of drugs by covalent attachment, adsorption or entrapment. 
Target biomolecules such as antibodies and nucleic acids can also be 
conjugated to functionalized nanoparticles. Thus, surface engineering of 
nanoparticles results in their applications in various fields. 
 
1.3 Bio-analytical applications of magnetic nanoparticles 
In the last two decades, magnetic nanoparticles are extensively being used in 
number of bioanalytical applications.4, 14, 15 The use of magnetic nanoparticles 
can be classified based on their in vivo and in vitro applications. In vivo 
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applications of magnetic nanoparticles includes their effective use as contrast 
agents in magnetic resonance imaging (MRI), selective destruction of malignant 
tissues through heating by a technique called hyperthermia and as site selective 
delivery vehicles for drugs. In vitro applications of magnetic nanoparticles include 
their use as separation tools in nano and microfluidic devices as well as 
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1.3.1 Drug targeting 
SPIONs can deliver the drug to the site of interest by passive, active and physical 
targeting. In passive targeting, drug is delivered to the specific sites by the 
special properties of carriers. In active targeting, drug is delivered to specific sites 
by special recognition mechanisms. A key advantage to utilizing SPIONs for drug 
targeting is that in physical targeting, drug is delivered to the specific site by 
means of external forces such as magnetic field.6 
 
Colloidal systems with sizes below 500 nm are used as drug carrier systems 
which include microparticles, nano and microemulsions apart from nanoparticles. 
There are several vital factors such as size, mobility, surface charge, toxicity, 
density and molecular weight which play an important role in the distribution of 
these carrier systems within the body system.  
 
1.3.1.2 Intake of nanoparticles by cells 
The size of nanoparticles plays an important role in the uptake and elimination of 
nanoparticles or nano drug delivery vehicles.16 The mechanism of cellular uptake 
of nanoparticles has been investigated previously. Almost all the nanoparticles 
used for biological applications are hydrophilic and are dispersed in aqueous 
solutions. These particles cannot pass through the hydrophobic plasma or cell 
membrane. Nanoparticles are known to be taken up by the cells by endocytosis 
mechanism.16, 17 Endocytosis is a process wherein the plasma membrane 
invaginates to form vesicles that can enclose the extracellular components and 
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take them up into the cells. There are several types of endocytosis including 
receptor mediated endocytosis, phagocytosis (cell eating) and pinocytosis (cell 
drinking). Reportedly, nanoparticles enter the cells via receptor/clathrin-mediated 
endocytosis.17 In this type of endocytosis, clathrin protein coated pits are formed 
in the plasma/cell membrane when the target particles bind to the receptor 
proteins on the plasma membrane and buds to form cytoplasmic vesicles.18  
 
1.3.2 Magnetic Resonance Imaging 
Magnetic resonance imaging is based on the principles of NMR. It is a widely 
used non-invasive diagnostic method mainly for soft tissues and cartilages based 
on the difference in relaxation times of hydrogen atoms. SPIONs are widely used 
as MRI contrast agents due to this difference in hydrogen atom relaxation 
times.19 However, use of SPIONs depends on its physicochemical properties 
such as size, surface charge and surface coatings. Biocompatible surface 
coatings such as dextran, starch, poly vinyl acid, polyacrylic acid and poly 
ethylene glycol have been used on SPIONs.20-23 The efficacy of SPIONs as MRI 
contrast agents can be increased by using biologically active ligands like 
antibodies, DNA and proteins for surface modification. Currently, a number of 
SPIONs exist in clinical trials or involved in experimental study stages, examples 
including Lumiren® for bowel imaging, Feridex IV® for liver and spleen imaging 
and Combidex® for lymph node metastases imaging.24 
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1.3.3 Hyperthermia 
SPIONs are used in the hyperthermic treatment of tumors. The exposure of 
SPIONs to alternating magnetic fields induces oscillation of magnetic moment in 
the particles; magnetic field energy is transformed into heat and liberated into 
tissue environment. This heating at high temperature (42 – 46 ºC) causes 
irreversible damage to tumor cells as opposed to reversible damage of healthy 
cells. Hence, hyperthermia is very useful cancer treatment. Microwaves, 
ultrasound, infrared and radiofrequency were successfully used conventionally 
for hyperthermia treatment. However, these techniques lack selectivity and could 
not induce heat in a specific tissue and temperature distribution is 
inhomogeneous. SPIONs, due to their smaller size, are absorbed into cells at a 
higher rate and homogenously distributed in the tissue. 
 
1.3.4 Biological molecule separations 
Magnetic properties of the magnetic nanoparticles in the presence of external 
magnetic field made them as attractive tools for bioseparations.25-28 Magnetic 
nanoparticles have been widely used in purification processes and 
immunoassays. Magnetic micro and nanoparticles were used for effective 
immobilization and separation of several biomolecules.29, 30 Due to their small 
size, magnetic nanoparticles can be effectively used as “mobile substrates” in 
bio-assays. They can also be conveniently incorporated into micro and 
nanofluidic devices.25 Magnetic particle based biosensors are widely used for 
detection of small quantities of biomarkers in clinical diagnostics.31 Magnetic 
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particles are coupled to antibody or aptamer for target binding. They provide 
efficient target capture and convenient separation. Magnetic field flow 
fractionation(MFFF) and electrical field flow fractionation (ElFFF) have been used 
for separation of variable size magnetic nanoparticles.32 Wang et al. showed the 
use of superparamagnetic microspheres in affinity adsorption of glutathione, a 
tripeptide found in mammals.33  
 
Magnetic particles help in pre-concentration and effective separation of analytes. 
They also offer advantages over filtration, centrifugation and solid-phase 
extraction. Processes using magnetic particles are less tedious and less time 
consuming. Magnetic micro and nanoparticles with high surface area account for 
minimum steric hindrance, effective surface reaction efficiencies and improved 
capture efficiency. Magnetic separation is simple and involves application of high 
magnetic field strength to separate the magnetic particles from its carrier 
solution. However, time required for magnetic separation depends upon the size 
and stability of magnetic nanoparticles in solution as well as strength of the 
applied magnetic field. 
 
Okamoto et al. reported the use of magnetic microspheres for online 
preconcentration and selective separation of lipoproteins by affinity CE.34 In this 
work, multifunctional magnetic microspheres (MFMPs) with a coating of cationic 
fluorescent tag and anionic affinity ligands on the surface are used. MFMPs are 
mixed with sample analyte and injected into the capillary as a plug. Online 
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trapping and preconcentration of analytes is achieved by applying a magnetic 
field on the capillary. On removing the magnetic field, the analytes move towards 
the detector window and detected by laser induced fluorescence (LIF) detector. 
The concept of online preconcentration and selective separation using MFMPs is 
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Figure 1-3: Schematic of online preconcentration and selective separation of 
lipoproteins using multifunctional magnetic particles (MFMPs) in affinity CE 
(adapted from reference 28). 
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Magnetic micro and nanoparticles due to their high surface area enhance the 
specific interaction of affinity ligands (coated on their surface) with their targets, 
thus, helping in analyzing trace amounts of analytes. In my research work, I 
demonstrated the use of SPIONs as analytical sensing elements. I have also 




1.4 Objectives of my research: 
My research mainly focuses on synthesis of monodisperse SPIONs, surface 
coating of SPIONs with biocompatible polymers, and attaching biomolecules. 
These SPIONs are characterized using various analytical techniques such as 
transmission electron microscope (TEM), Fourier transform infrared spectroscopy 
(FTIR), Dynamic light scattering (DLS), x-ray diffraction (XRD) and UV-Visible 
spectroscopy (UV-Vis). SPIONs are also demonstrated as excellent capture 
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Pluronic triblock copolymer-modified mono disperse Superparamagnetic Iron 













Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are extensively being studied 
for cancer therapy due to their use in targeted drug delivery, contrast enhancement in 
Magnetic Resonance Imaging (MRI) and hyperthermia for localized cell death.1, 2 In the 
last two decades, the use of magnetic nanoparticles in biomedical applications has 
increased significantly especially in the treatment of cancer through tumor targeting.3, 4  
 
Successful use of nanoparticles in biomedical applications is highly dependent on the 
stability of these particles under in-vivo conditions. The ability to stabilize and disperse 
the nanoparticles in an aqueous environment and modify the surface with molecules, 
proteins or other targeting agents is a crucial step for biomedical applications and 
bioanalysis.1, 5 Magnetic nanoparticle mediated drug delivery potentially reduces the 
drug dose, while improving drug efficiency. These effects are due to the poor lymphatic 
drainage of the cancer cells resulting in enhanced permeability and a retention affect of 
nanoparticles at the tumor site (also known as passive targeting).6 Surface modification 
of the nanoparticles with polymers helps to avoid uptake by the reticulo-endothelial 
system and mononuclear phagocytes7 and provides long circulation times of 
nanoparticles. Apart from drug delivery, magnetic nanoparticles can also be used for 
simultaneous Magnetic Resonance Imaging and hyperthermia treatment of cancer 





Although there are different methods of synthesizing SPIONs9, 10, the chemical co-
precipitation method using iron salts is the most commonly employed methodology.11 
However, this method often produces polydisperse materials.11 In this study, thermal 
decomposition of iron pentacarbonyl in the presence of oleic acid as a surfactant was 
used to synthesize uniform, monodispersed and unaggregated SPIONs to facilitate our 
study of the effects of polymer modification with the exclusion of structural variation. The 
particles as-synthesized are hydrophobic, and were modified by adsorption of Pluronic 
triblock copolymers to facilitate aqueous dispersion and stability. A number of methods 
have been described in the literature for surface modification of similar SPIONs for 
targeted drug delivery.12, 13  
 
Amphiphilic Pluronic tri-block copolymers are approved by FDA for use in humans and 
are currently being used as a part of drug and gene delivery systems.14-16 Commercially 
available, Pluronic tri-block co-polymers were used here to provide water solubility and 
prevent aggregation and simultaneously create a hydrophobic region within each 
SPION-Pluronic conjugate which is capable of holding hydrophobic drug molecules. 
Pluronics are triblock co-polymer surfactants (PEO-PPO-PEO) with hydrophobic 
polypropylene oxide (PPO) units sandwiched between hydrophilic polyethylene oxide 
(PEO) chains. The composition of the Pluronic dictates the surfactant Hydrophilic-
Lipophilic Balance (HLB). The HLB value of a surfactant is a semi-empirical measure of 
the degree to which it is hydrophilic or lipophilic based on emulsification behavior, with 
higher HLB indicating greater hydrophilic nature. For Pluronics, the relative size of 




number of ethylene oxide (EO) units in the Pluronic, yields a higher HLB value.  A block 
diagram of a Pluronic structure is given in Figure 2-1 and a summary of the Pluronics 




























Figure 2-1: Pluronic Block Diagram showing the hydrophobic  polypropylene oxide 
units(PPO) sandwiched between hydrophilic polyethylene oxide units (PEO) 
 
 





# of PPO 
Units[Y] 
# of PEO 
Units[2X] 
HLB Value CMC[M] 
P 123 5750 69 38 7 – 12 4.4 X 10-6 
P 85 4600 40 52 12 – 18 6.5 X 10-5 
F 127 12600 65 200 18 – 23 2.8 X 10-6 







Although Pluronic-coated SPIONs have been studied by Jain and co-workers,8, 17, 18 the 
SPIONs used were produced by co-precipitation; thus phase transfer is not an issue as 
the synthesis and modification of SPIONs with polymers both occur in aqueous phase. 
This could cause variability in SPION stability since the surface of the SPION is 
hydrophilic and could be expected to interact with the Pluronic differently. Other 
methods have also been proposed for the phase transfer of SPIONs from organic to 
aqueous phases19-21 which typically resulted in low concentrations of material and there 
for requiring excessive processing times.  
 
The method described herein is a technically simpler and faster approach of phase 
transfer for the production of water soluble SPIONs. This approach was used with the 
selected Pluronics, which covered a wide range of molecular weights and HLB values, 
to specifically study the physical structure-property relationships in SPIONs. By using 
the same SPION core throughout this work, the described experiments probed the 
effect of the Pluronic on the hydrodynamic size of the SPION-Pluronic conjugate and 
the potential impact on drug delivery. A drug model, the fluorescent dye 1,1’-
dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine perchlorate (DiI) (chemical structure 
shown in figure 2-2) was used for determining drug loading capacity, the results of 























R = (CH2)17 
 
Figure 2-2: Structure of 1,1’-dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine per 





OA-SPIONs that were surface coated pluronic were made by a simple and efficient 
method. Both OA-SPIONs and pluronic-OA-SPIONs were characterized by various 
analytical techniques so as to evaluate the role of PEO and PPO units of Pluronic 
polymers on hydrodynamic size and stability. Furthermore, the mechanism of 
polymer assembly on the SPION surface based on the properties of different 



























































2.2.1 Materials and Methods 
2.2.1.1 Reagents and materials  
All chemicals including Iron pentacarbonyl, Oleic acid, Trimethylamine N-oxide and 1-1’-
dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine perchlorate (Dil) –were purchased 
from Sigma Aldrich (St.Louis, MO, USA). Solvents including toluene, hexane and 
ethanol were obtained from Fisher Scientific (Pittsburgh, PA, USA). Pluronic samples 
were obtained as gift from BASF chemical company (Florham Park, NJ, USA). 
  
2.2.1.2 Synthesis of monodisperse magnetic nanoparticles by thermal 
decomposition 
The nanoparticles were synthesized by thermal decomposition method as previously 
described. 9  A solution of Oleic acid (5.12 g, 18.1 mmol) in octyl ether (40 mL) was 
heated at 100oC  Fe (CO)5 (0.8 mL, 5.93 mmol) added the mixture then heated at reflux 
for 1 h and then cooled to room temperature.  Solid anhydrous trimethylamine N-oxide 
(1.36 g, 18.1 mmol) was then added and the mixture heated at 130 0C for 2 h (the 
reaction mixture becomes brown).  The mixture was then heated at reflux for an 
additional hour (becomes black in appearance).  Cooled to room temperature, ethanol 
added to remove the excess oleic acid, and then this mixture was dispersed in toluene 






2.2.1.3 Preparation of Pluronic coated OA-SPIONs 
Oleic acid-coated SPIONs (12 mg) in toluene (2 mL) were added to a Pluronic(48 mg) 
dissolved in distilled water (8 mL), cooled to 0 ºC and subjected to horn ultrasonication 
for 30 min. The ultrasonication resulted in an emulsion of toluene in water containing 
Pluronic-coated SPIONs. The emulsion was broken using ultracentrifugation at 14,000 
rpm for 15 min. The aqueous layer turned brown in color, indicating the presence of the 
Pluronic-coated SPIONs that were carefully separated from the toluene using a syringe. 
Excess Pluronic in these samples was removed using centrifuge filters with a 100 kDa 
molecular weight cut-off at 2,000 rpm for 15 min. This purification was repeated three 
times to ensure the samples were free of excess Pluronic. Pluronic-coated SPIONs 
were redispersed in deionized water (picture of solutions shown in figure 2-4). These 











Figure 2-4. From left to right: Water, P 123 coated SPIONs, P 85 coated SPIONs, F 
127 coated SPIONs, F 108 coated SPIONs, oleic acid coated SPIONs. All pluronic-
SPIONs as aqueous dispersions at the same concentration; oleic acid-SPIONs in 
toluene. 
 
2.2.1.4 Loading of DiI dye onto Pluronic coated SPIONs 
The carbocyanine dye, 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine 
perchlorate (DiI) is a water-insoluble dye used as a drug analogue in our study. A stock 
solution of 0.2 mg/mL in DMF was used for all experiments. To the 1.5 mL of 1mg/mL 
Pluronic coated SPIONs samples, 0.5 ml of 0.2 mg/mL DiI dye in DMF was added and 
stirred for 48 h. During this time, the dye molecules partition into the hydrophobic region 
of the Pluronic-SPIONs defined by the oleic acid and PPO region of the pluronics. The 
amount of drug entrapped by each SPION is proportional to the hydrophobic region of 
the particle. After 48 h, the dye-loaded Pluronic-SPIONs were separated from the dye 
solution using a strong magnet and resuspended in deionized water. Dye-loaded 
Pluronic-SPIONs dispersed in water were then analysed by absorption spectroscopy at  




was calculated using a calibration curve. Entrapment efficiency is given as a ratio of 
drug/dye loaded onto SPIONs to the total drug/dye used.  
 
2.2.2 Characterization  
Transmission Electron Microscopy : The morphology and size of the SPIONs was 
characterized by TEM (JEOL-JEM-2100) operating at an accelerating voltage of 80 kV. 
A drop of the nanoparticle sample was placed on a carbon coated 200 mesh Cu grid 
sample holder, followed by drying the sample at room temperature. 
X-Ray Diffraction: A SPION sample was characterised by room temperature XRD. 
Diffraction patterns were collected with a Rigaku diffractometer using CuKα radiation 
(λ=0.154185nm) in the scanning range of 2θ = 150 to 1000. 
Dynamic Light Scattering:  Measurements were recorded using a Zetasizer Nano 
(Malvern UK) at a detection angle of 173 0 with a 3 mW He-Ne laser operating at 633 
nm. DLS was used to measure the hydrodynamic diameter of the SPIONs dispersed in 
toluene and Pluronic coated SPIONs of each kind dispersed in water at 25 0C.  
Fourier Transform Infrared Spectroscopy: FTIR Spectroscopy was used to verify 
functional group modification of SPIONs after synthesis and modification with pluronics. 
Spectra were collected on samples that were dried on ATR sampling accessory of FTIR 
(Perkin Elmer) and the percent transmittance spectrum was taken over a range of 4000-




Thermogravimetric Analysis: Therrmogravimetry of the SPIONs and Pluronic coated 
SPIONs was studied by using TGA 7 (Perkin Elmer) . Samples were heated to 800 ºC in 
a stream of Argon gas (20 ml/min) at a rate of 20 ºC/min and were held at 800 ⁰C for 30 
min. 
Absorption Spectroscopy: Absorption spectra of the dye loaded Pluronic coated 
SPIONs were obtained using Cary 50 UV-Visible Spectrophotometer. The spectra were 
recorded from 300 to 800 nm. 
 
2.3 Results and Discussion 
2.3.1 Particle Size  
As previously reported by others22, the SPIONs prepared by thermal decomposition 
were well dispersed and monodisperse with an average particle size of 10.1 ± 0.9 nm 
(Figure 2-5a).  The size distribution was determined by algorithmic analysis of 
measurements taken for ~500 nanoparticles using Image J. SPIONs synthesized by 
thermal decomposition are highly crystalline as evidenced by HRTEM images shown in 
inset of Figure 2-5a. Lattice planes are clearly visible and the lattice spacing is 
consistent with the <206> plane of γ-Fe2O3, maghemite. From DLS, the hydrodynamic 
size of the oleic acid-coated SPIONs (OA-SPIONs) is found to be approximately 11.8 ± 
0.1 nm. This size is consistent with that determined by TEM, given that TEM neglects 
the presence of the oleic acid surfactant, and the DLS measurement includes 





A TEM image of Pluronic coated SPIONs is shown in Figure 2-5c and no observable 
change in crystallinity was observed. An increase in the distances between particles 
(corresponding to a larger surfactant layer) was not observed between the OA-SPIONs 
and Pluronic coated nanoparticles. This is because, it is hard to see the organic polymer 
coating clearly with TEM. However, we could see the formation of cluster like structures 
with the Pluronic coated SPIONs on the carbon grid indicating the phase transfer of 
SPIONs. The formvar coated Cu grid used for the TEM sample preparation is 
hydrophobic and since the OA-SPIONs in toluene are coated with Pluronics and 
transferred to aqueous phase, the particles are not spread out uniformly on the grid. 
That is why the TEM image of Pluronic coated SPIONs were seen as clusters rather 
than single particles. However, DLS results (Figure 2-8) support that the Pluronic coated 











Figure 2-5. a) TEM image of OA-SPIONs in toluene; inset shows HRTEM image of 
OA-SPIONs showing crystal lattice b) Size distribution of OA-SPIONs by image J      





In figure 2-6, the XRD pattern of the iron oxide nanoparticles is shown. XRD was 
performed to determine the crystal lattice parameters of the magnetic nanoparticles. 
XRD analysis indicates that the synthesized particles were γ-Fe2O3 (Maghemite) based 
on the positions of peaks. XRD peak analysis and fitting to the Scherrer equation gave a 



















Figure 2-6. XRD patterns of oleic acid coated SPIONs synthesised by thermal 










2.3.2 Pluronic adsorbed on SPIONs 
The preparation technique described here takes advantage of the tendency of the 
Pluronic block copolymers to adsorb to hydrophobic surfaces through the central PPO 
block, with the PEO blocks projecting away from the surface. This phenomenon has 
been extensively studied with respect to Pluronic adsorption on flat surfaces, particles 
and vesicles.23-26 Here, the adsorption of the Pluronics to the hydrophobic OA-SPIONs 
imparts aqueous solubility to the SPIONs, and increases the volume of hydrophobic 
materials at the SPION surface into which hydrophobic drug molecules will selectively 
partition.  Excess Pluronic molecules were removed from the Pluronic SPIONs 
suspension through the use of centrifuge filters with a molecular weight cutoff of 100 
kDa. This is much higher than the molecular weight of even the largest of the Pluronics, 
and empirical examination showed no passage of Pluronic-SPIONs through the filter. To 
confirm that the Pluronics were adsorbed onto the SPIONs, the OA-SPIONs and 
Pluronic-SPIONs were analyzed by FTIR, DLS and TGA. 
The FTIR spectra of OA-SPIONs, Pluronic and Pluronic-OA-SPIONs are shown in 
Figure 2-7. The OA-SPIONs show strong peaks corresponding to methyl/ethylene 
symmetric/asymmetric stretches at 2750-3000 cm-1 along with carboxylate anion 
stretches at 1467 cm-1 and 1526 cm-1, confirming the presence of oleic acid on the 
synthesized particles.  After Pluronics were adsorbed onto the exterior of the SPION, 
the intensity of these peaks is attenuated by the coating of Pluronic co-polymer. All the 
Pluronic-SPIONs show spectra consistent with free Pluronic in solution shown as a 









Figure 2-7. FTIR spectra of OA-SPIONs, Pluronic-OA-SPIONs and free 












Pluronics of various sizes were adsorbed to the OA-SPIONs. Two primary possibilities 
exist for adsorption mechanisms of Pluronics to the hydrophobic OA-SPIONs: 1) the 
PPO block interacts with the surface of the OA-SPIONs, or 2) the PPO block 
interpenetrates the OA surfactant layer on the SPIONs. In either case, the adsorption of 
the Pluronics onto the OA-SPIONs will be self-limiting due to the loss of conformational 
entropy of the PEO (entropy associated with the compact physical arrangement of PEO 
chains of polymer in solution). 
 
  
From the DLS results (shown in figure 2-8), we can observe that with the increase in 
molecular weight of the Pluronics and the PEO subunits, the hydrodynamic size of the 
pluronic-SPIONs increases. However, we could see a discrepancy in the trend with P 
123. Though P 123 has fewer PEO units, it has higher hydrodynamic size than F 127. 
This might have been due to the formation of micelles. We observed almost similar 
results with these systems when checked after 6 months for their stability over time. 
This reveals that this novel method followed for the phase transfer of SPIONs results in 































































































Figure 2-8. a) Graphical Representation of hydrodynamic size variation of Pluronic 





Thermo gravimetric analysis was used to understand the mass relationship between the 
surfactant layer and iron oxide core of the particles allowing estimation of the surface 
coverage for each system. All the Pluronic-coated SPION samples began losing mass 
at 150 ºC and stabilized by ~500 ºC as seen in Figure 2-9 as determined from the first 
derivative curves of TGA data. Oleic acid-coated SPIONs lost mass beginning ~220ºC. 
Assuming that the Pluronic block co-polymer is desorbed from 200ºC to 500ºC, the 
percent coating on the SPIONs was calculated and is shown in Table 2-2. From 
consideration of the TGA data of the OA-SPIONs (Figure 2-9), oleic acid represents 
22.6 % of the total coating in all the samples and the remaining percentage of coating is 
the Pluronic. These results suggest that the P123 and F127 SPIONs are coated well 















Figure 2-9. TGA of SPIONs and Pluronic coated SPIONs showing the degradation of 
organic polymer at high temperatures 
 


















OA-SPIONs 205.14 96.22 500.09 73.58 22.65 
P85 205.46 82.16 500.60 47.28 34.87 
P123 205.32 97.39 500.33 52.32 45.06 
F127 205.40 93.58 500.41 47.27 46.31 





Though P123 is the smaller molecule (MW 5750 AMU) the TGA results of P123-
SPIONs suggest that it behaves similar to that of F127-SPIONs i.e. it showed similar 
surface coverage as that of F127. Both F127 and P123 have equivalent percent weights 
of Pluronic coating as per the TGA analysis from Table 2-2. This can be attributed to 
their similar number of PPO groups (69 in P123 and 65 in F 127) that helps in the 
attachment of Pluronics to the SPIONs. As expected, P85 with fewest number of PPO 
units and low molecular weight showed the smallest percentage of Pluronic coating on 
SPIONs, which  supporting the proposed role of PPO in the adsorption of pluronic onto 
SPION. F108-SPIONs showed a higher percentage of Pluronic coating compared to 
P85-SPIONs and lesser coating compared to P123 & F127-SPIONs also supporting the 
role of PPO in the adsorption of Pluronic on SPION. 
 
 
2.3.3 Loading of hydrophobic dye DiI onto Pluronic coated SPIONs 
Absorption spectroscopy was used to determine the absorbance of dye encapsulated 
by Pluronic-OA-SPIONs and all the samples showed a distinct absorption double peak 
similar to that of standard solutions of dye (shown in Figure 2-10a). Since the λmax of the 
dye adsorbed onto SPIONs has shifted, absorbance at 590 nm is taken both for 
Pluronic-SPIONs and dye loaded Pluronic SPIONs. Here, we are assuming that the 
molar absorptivity of the dye remains the same even on the nanoparticle surface, which 
may not be true. Hence, the calculated values (based on background subtracted 




shown remains the same. A calibration curve was derived from carbocyanine dye 
solutions of known concentrations yielding a linear fit of y= mx +c. Percent entrapment 
efficiency of the Pluronic coated SPIONs was calculated from the calibration curve. 
 
% Entrapment or loading efficiency is given by:     
(Dye loaded onto SPIONs (μg/mL) / Total dye used for loading (μg/mL)) *100 
Refer to the sample calculation is given on pg. 66 in chapter 3. 
The comparison of hydrophobic dye entrapment efficiency of OA-Pluronic SPIONs is 
shown in Figure 2-10b. The drug encapsulation efficiency increased with the increase in 
molecular weight and size. SPIONs coated with Pluronic F108 showed the highest dye 
entrapment efficiency followed by the Pluronic F127. Thus the structural and molecular 
size properties of the Pluronics on the SPIONs play a major role in the drug storage 
capacity. The larger entrapments are attributed to larger hydrophobic regions being 







   
 
































Figure 2-10. a) UV-Visible absorbance of OA-Pluronic SPIONs with entrapped DiI dye 







2.4 Conclusions & Future directions 
A simple, novel and fast approach of coating Pluronics onto uniform monodisperse 
SPIONs has been developed and has proved to be successful in producing potentially 
biocompatible aqueous solutions of maghemite. This study on hydrodynamic diameter 
variations and thermo gravimetric analysis of various Pluronic coated SPIONs clearly 
indicated that the structure and molecular weight of Pluronics play a major role in the 
attachment of these polymers onto SPIONs and also demonstrated their effect on drug 
analogue entrapment efficiency based on the absorbance data. 
 
 These absorbance measurements and comparison of drug loading efficiencies can be 
considered as qualitative or semi quantitative. Quantitative measurements can be 
achieved by separating SPIONs from supernatant using ultracentrifugation and then 
measuring the drug in both fractions. In this method, if the molar absorptivity (ε) of the 
dye is affected by interaction with the SPION coating the absorbance can be 
determined by the method of standard addition. If this is not feasible e.g. due to dye 
saturation, then after separating the SPIONs from supernatant the dye can be released 
in an organic solvent, recovered and reconstituted in a solvent equivalent to the 
supernatant and measured with UV-Vis absorbance. 
 
 Pluronic F127 and F108 were found to be the most efficient of polymer coatings for 
drug encapsulation studied here. The comparison of entrapment efficiency of these 




However, release and bioavailability of drug in the biological environments is more 
important for its in vivo applications. Now that the entrapment efficiency of Pluronic 
SPIONs is characterized, the next step towards the clinical development is to study the 
drug release properties in-vitro from these systems produced by the new approach 
described here. 
 
Tri block co-polymers Pluronics are commercially available and are FDA approved. 
Pluronic coated oleic acid-SPIONs can be used for loading hydrophobic drugs for 
targeted drug delivery by passive targeting. However, Pluronic polymers lack a 
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Antisense Survivin coupled surface modified magnetic nanoparticles for 













In the previous chapter SPIONs were synthesized by thermal decomposition and 
surface modified with tri-block co-polymers, Pluronics. To these surface modified 
SPIONs, a hydrophobic dye was loaded as a surrogate to drug.  However, 
Pluronics lack the functional groups necessary to attach the biomolecules such 
as antibodies and nucleic acids that may help in active targeting for drug delivery 
as well as magnetic resonance imaging. Hence, this chapter demonstrates the 
possibility of using a co-polymer with a functional group useful for attaching 
nucleic acid ligands onto SPIONs. An anti cancer drug, epirubicin was also 
loaded onto these functionalized SPIONs. 
 
Nanoparticles possess distinct physical and chemical properties which make 
them unique for many applications such as biosensing, drug delivery and 
separations.1-5 Magnetic nanoparticles in particular offer several advantages. 
Superparamagnetic iron oxide nanoparticles (SPIONs) have been demonstrated 
to be biocompatible with living systems. Hence SPIONs are under investigation 
for use in a wide range of human health applications, including targeted drug 
delivery, MRI contrast enhancement and hyperthermia.6-8 To achieve these 
goals, control of particle structure, function, and stability in physiologically 
relevant conditions is critical.9  
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Currently a number of SPIONs based therapeutics are under investigation, 
examples include Lumiren® for bowel imaging, Feridex IV® for liver and spleen 
imaging, Combidex® for lymph node metastases imaging, and Ferumoxytol ® for 
iron replacement therapy.10 However, these SPIONs lack multifunctional 
properties such as specific targeting of drug delivery or imaging. Though the 
passive targeting of nanoparticles is possible for using them in cancer therapy, it 
is neither homogenous in all tissues nor effective in all types of cancer. To 
overcome this limitation, use of active targeting by functionalizing nanoparticles 
with different biomolecules is proposed. 
 
DNA sequences that interfere with protein expression (Antisense DNA) are 
effective in treatment of cancer.11-13 Survivin, a protein over expressed in many 
cancer types, inhibits apoptosis which allows cancer cells to grow unchecked. 
Survivin has also been shown to be one of the most cancer-specific proteins 
identified to date, being up-regulated in almost all human tumors. It is known to 
have roles in the apoptosis (programmed cell-death) pathway, enhancing cell 
proliferation, and promoting angiogenesis, the development of new blood 
vessels14, 15. The use of antisense DNA in therapies targeted at reducing the 
expression of survivin may be effective in treating cancer. Recent results have 
shown that antisense DNA coupled to nanoparticles has an increased 
effectiveness compared to unconjugated DNA. 
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The goal of this work was to develop a stable, highly effective SPION-based 
platform which can be targeted to specific cell types and serve as a vehicle for 
therapeutic drug delivery all the whole providing enhanced imaging contrast. The 
central hypothesis is that functionally modified SPIONs will preferentially target 
cancerous cells and thereby effectively delivering therapeutically significant 
concentrations of anti-tumor drugs. Three specific aims further explain the overall 
objective of this work: 1) identify design parameters for SPIONs that optimize 
aqueous stability and maximize amphiphilic character, 2) evaluate drug storage 
characteristics of SPIONs, and 3) demonstrate binding of antisense survivin DNA 
to SPIONs. Here, the amphiphilic shell coating the SPION core was 
functionalized with a targeting ligand. This targeting mechanism was then tested 
in A549 cancer cells, which overexpress the apoptosis inhibitory protein, 
Survivin. Targeting the Survivin mRNA sequence has been shown an effective 
antisense target suppresses survivin production and is used as the basis for 
SPION specificity.15 The antisense oligonucleotide sequence (aSL) used was: 
5’CCCAGCCTTCCAGCTCCTTG-(CH2)6-
3’NH2. This oligonucleotide sequence 
was coupled to the biocompatible SPION and the reaction conditions for this 
process were optimized. Coupling of oligonucleotide to SPION is measured by 
spectroscopic techniques.  
 
In this work, we focus on drug loading and molecular targeting for drug delivery. 
Epirubicin is a potent anticancer drug, but systemic dosing causes undesired 
side effects, including immune system suppression, since epirubicin affects 
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healthy cells as well as cancer cells.16 Specific targeting of epirubicin release to 
cancer cells can increase the bioavailability of drug while reducing side effects to 
the patient. Here we report the loading of fluorescent anticancer drug Epirubicin 
(figure 3-1) onto modified SPIONs and the conjugation to tumor targeting 

























































































3.2.1 Materials and methods 
Epirubicin (EPI) in the form of the hydrochloride salt was purchased from Sigma-
Aldrich. EPI base was prepared by mixing EPI with three equivalents of 
triethylamine (TEA) in dimethylformamide. Phosphate buffer saline (PBS) was 10 
mM sodium monobasic phosphate, 2 mM potassium dibasic phosphate 
containing 137 mM sodium chloride and 2.7 mM potassium chloride, pH 7.4. All 
chemicals including Iron pentacarbolyl, Oleic acid, Trimethylamine N-oxide were 
purchased from Sigma Aldrich (St.Louis, MO, USA). All the solvents which 
include DMF, triethylamine, toluene, hexane and ethanol are obtained from 
Fisher Scientific (Pittsburgh, PA, USA).  
 
All reactions were conducted under an inert nitrogen atmosphere unless 
otherwise noted.  For oligo synthesis:  phosphoramidite DNA bases, fluorophore 
phosphoramidites and CPG columns were obtained from Glen Research 
(Sterling, VA).  Oligonucleotides were prepared on an ABI 391 DNA synthesizer 
using standard coupling conditions except for the fluorophore phosphoramidite 
for which 3 min coupling time was used. The antisense survivin ligand (aSL) 
oligonucleotide was prepared without and with a fluorophore (f-aSL). In the case 
of f-aSL, the fluorophore was located on the 5’-terminus and added during 
synthesis.  The sequences of the oligonucleotides prepared were 
5’CCCAGCCTTCCAGCTCCTTG-(CH2)6-
3’NH2 (aSL) and reverse complement 
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5’CAAGGAGCTGGAAGGCTGGG3 (aCS) with the 5’-trityl group removed at the 
end of the synthesis. 
 
3.2.2 Synthesis and characterization of OA-SPIONs 
The oleic acid SPIONs (OA-SPIONs) were synthesized by a thermal 
decomposition method. The OA-SPIONs were well characterized by various 
analytical techniques such as transmission electron microscopy (TEM), dynamic 
light scattering (DLS), fourier transform infrared spectroscopy (FTIR) and thermo 
gravimetric analysis (TGA). The synthesis and characterization of OA-SPIONs 
are described in detail in Chapter 2. The same batch of SPIONs was used here 
in this work for surface modification using a different polymer with a functional 
group: 40% octylamine modified polyacrylic acid. 
 
3.2.3 Surface modification of SPIONs by modified polyacrylic acid 
Modified polyacrylic acid (PAA) has been previously used as a coating for the 
quantum dots for phase transfer and achieved a good yield.17, 18 Briefly, 1800 
molecular weight polyacrylic acid powder(2.5 g, 1.39 mmol) was diluted in dry 
N,N-dimethylformamide (35 mL) and EDC-HCl (2.66 g, 13.9 mmol) was 
dissolved. The solution was stirred for 30min followed by the addition of 
octylamine (2.3 mL, 13.9 mmol). The solution was stirred at room temperature 
overnight. Deionised water was added to precipitate the polymer which was 
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isolated by centrifugation. Excess water was discarded. An aqueous solution of 
1M NaOH was added and solution was shaken overnight to resolubilize the 
polymer in water. Crude modified solution obtained was washed by ethyl acetate 
to improve the clarity of aqueous polymer suspension. The polymer was re-
precipitated by adding dilute HCl to adjust the pH to 5. Solid product was 
collected by centrifugation and dried under vacuum. The final product was 
carefully neutralized using 0.1M NaOH solution and lyophilized for storage. This 
gives 40% octylamine modified PAA polymer which will be referred to as 
modified PAA copolymer.  
 
OA-SPIONs were coated with the modified PAA copolymer by mixing solutions of 
each in miscible solvents (toluene and chloroform respectively). The solvents 
were evaporated by vacuum centrifugation and the PAA-OA-SPIONs were 
redissolved or resuspended in DI water at basic pH ~8 by sonication for 2hrs at 
room temperature. 
 
3.2.4 Oligonucleotide Synthesis and purification 
Oligonucleotides were prepared on a 1 μmol scale using an ABI-394 DNA and 
RNA Synthesizer using the standard coupling cycle and times.  All 
oligonucleotides bore a 3’ amino linker (6 carbon) so that they could be coupled 
to the SPIONs.  The aSL oligonucleotide was prepare without and with a 
fluorophore (f-aSL), In the case of f-aSL, the fluorophore located on the 5’-
Chapter 3 60
terminus and added during synthesis.  The sequences of the oligonucleotides 
prepared were 5’CCCAGCCTTCCAGCTCCTTG-(CH2)6-
3’NH2 (aSL) and 
5’CAAGGAGCTGGAAGGCTGGG3 (aCS) with the 5’-trityl group removed at the 
end of the synthesis.  Oligonucleotides were cleaved off the resin by treatment 
with concentrated NH4OH (28-30%, 1 ml) at room temperature for 1 hour and 
filtered through 0.2 μm filter disk.  The cleavage of protecting groups was 
accomplished by heating the filtrate at 55oC for 20 h and then dried down in a 
SpeedVac. Final purification of oligomers was achieved by (FPLC) using a Bio-
Rad TSK DEAE-5-PW column.  Both oligonucleotides were purified using a linear 
gradient (10-70% B over 60 min, Buffer A: 10 mM NaOH, pH 11.8, Buffer B: 10 
mM NaOH, 1 mM NaCl, pH 11.8, flow rate 7 ml/min, UV detection, 260 nm).  The 
oligomers were desalted with reverse phase Waters Sep-Pack (C-18) cartridges 
by 60% MeOH/water elution.   
 
3.2.5 Coupling of antisense Survivin to SPIONs 
Conditions required for coupling of DNA were optimized. SPIONs (1 mg) in water 
were treated with EDC in solvent for 30 min and then an aqueous solution of the 
aSL oligonucleotide (1.5 mg) was added and the mixture allowed to react for 3 h 
at 50oC, with constant shaking. Excess DNA was removed from solution by 
filtration through a Vivaspin 100 kDa Molecular Weight Cut-off Filter (10 min, 250 
x g) washing three times with water.   
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3.3 Results & Discussion 
In our work, to transform the hydrophobic oleic acid-SPIONs to water soluble 
nanoparticles for biological applications we used an octylamine polyacrylic acid 
co-polymer to assist in phase transfer process as well as a means for coupling 
the targeting biomolecules for targeted drug delivery.  
 
An amphiphilic copolymer was prepared by coupling of octylamine to polyacrylic 
acid (PAA) backbone using EDC catalyzed coupling. Octylamine was coupled to 
approximately 40% of available carboxylic acid groups on PAA. This amphiphilic 
copolymer imparted aqueous stability to the SPIONs and provided coupling sites 
for attachment of targeting molecules. Copolymer structure was assessed by 
ATR-FTIR and dynamic light scattering. 
 
3.3.1 Fourier Transform Infrared Spectroscopy 
In figure 3-4, the prominent peaks at 2750-3000 cm-1 correspond to 
symmetric/asymmetric stretching mode of the methyl/methylene units in both 
oleic acid and the PAA-copolymer. The sharp peak at 1710 cm-1 in OA-SPIONs 
is the C=O stretch of oleic acid – the same region is broadened in the PAA-OA-
SPIONs due to the increased number of acids on the PAA-copolymer. The 
presence of peak at 1630 cm-1 is attributed to the amide C=O stretch from the 
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octylamine-modified polymer. These peaks assignments are in accordance with 



























Figure 3-3: FTIR spectra of A) SPIONs (black trace) and B) modified PAA 






3.3.2 Dynamic Light Scattering of PAA-OA-SPIONs 
The size and stability of modified PAA-OA-SPIONs in PBS (pH ~ 7.4) was 
studied by DLS and the average hydrodynamic radius found by intensity size 
distribution is 33 nm. The zeta potential of these particles was found to be - 82 
mV. At pH 7.4, the carboxylic acid groups on the PAA-OA-SPION surface should 
be largely deprotonated, providing a high stabilizing surface charge. This is 
supported by the zeta potential measured. 
 
3.3.3 Loading of Epirubicin onto PAA-OA-SPIONs 
The Epirubicin (EPI) is a water-insoluble anticancer drug used for our study. A 
stock solution EPI (0.5 mg/mL) in DMF was used for loading and making 
standards. To the 3.6mL of 1mg/mL PAA coated SPIONs samples in water, 
0.4mL of 0.5 mg/mL EPI in DMF was added and stirred for 48 h. During this time, 
the drug molecules partitions into the hydrophobic region of the  surface modified 
SPIONs. After 48 h, the drug-loaded PAA-SPIONs were separated from the drug 
solution using a strong magnet, supernatant drug solution was discarded and 
PAA-SPIONs were resuspended in deionised water. This process is repeated 
twice to ensure the removal of unadsorbed drug.  
 
The amount of Epirubicin loaded into the SPIONs by the solvent diffusion 
method, after stirring it overnight was determined by using the drug absorbance 
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in absorption spectroscopy at 485 nm wavelength. This first requires the 
preparation of a calibration curve and then measurement of the visible 
absorbance of the SPIONs in the absence and presence of Epirubicin (Figure 3-
5).  The ability of the SPIONs to entrap a drug is quantified by calculating the 
entrapment efficiency of the PAA coated SPIONs which is calculated using a 
calibration curve. This may be lesser than the actual loading efficiency of these 
systems since there might be change in molar absorptivity of dye on SPIONs. 
Calculations: 
Relative absorbance of EPI loaded SPIONs (obtained by subtracting absorbance 
of polymer-SPIONs from absorbance of EPI loaded polymer SPIONs) = 0.293 
EPI concentration loaded onto PAA-SPIONs (obtained from calibration plot)         
= 29 μg/mL 
Actual concentration of EPI used for loading = 50 μg/mL 
% loading efficiency (or) entrapment efficiency is given by:  
(Drug loaded onto SPIONs / Total drug used for loading) *100 








Figure 3-4. UV-Visible Spectroscopy of Epirubicin showing the spectra of 
standards ranging from 10 μg/mL to 80 μg/mL EPI with overlaid traces of EPI 







3.3.4 Coupling of fluorescent antisense survivin ligand (f-aSL) to SPIONs 
Fluorescence was measured using a Shimadzu RF-5301PC 
spectrofluorophotometer in emission mode, with a scanning range from 300-600 
nm. Fluorometric analysis of f-aSL alone and after coupling to the SPIONs was 
determined in water with λEx = 494 nm and λEm = 521 nm. Figures 3-5 shows 
results measured by fluorescence studies of fluorescein modified antisense 
Survivin oligonucleotides in solution as well as when coupled to SPIONs. Table 
3-1 shows the emission intensity of all the samples and the concentration of f-
aSL on SPIONs calculated from the calibration curve. Coupling of survivin to 
SPIONs and its characterization was conducted by Dr. Gannett’s group at health 




Emission @ 521nm 
SPION f-asL36 798 
SPION f-asL 17 332 
SPION f-asL 8.6 141 
SPION f-asL 4.9 50 
f-aSL 28 646 
f-aSL14 212 
f-aSL 7.0 85 
f-aSL 1.4 9 
 
Table 3-1: Data obtained from fluorescence spectroscopy showing the 





Figure 3-5: Emission spectra of f-aSL and SPIONs f-aSL at various 
concentrations. Emission peak is at 521 nm. 
 
In this figure concentrations associated with SPIONs are calculated from the 
calibration curve of f-asL. The slope and intercept obtained from linear regression 
are 24 ± 3 (μL/ng) and 70 ± 47. 
Based on fluorescence data obtained, number of f-aSL per SPION was 
calculated assuming that the quantum yield remains the same for fluorescein 
even after tagging to DNA and attaching to SPION. Each SPION was expected 




SPION density 5.24 g/cm^3 
SPION radius 5.01 nm 
Volume of SPION 523 nm3 
Mass of SPION 2.74E-18 g/particle 
Mass of SPIONs in 10mg sample 
of OA - SPIONs as per TGA 0.00775 mg 




@521nm Conc (ng/uL) Molarity moles 
molecules 
of f-aSL 





Conc (g/L) / 
332.31(g/mol) M * V (L) moles * A 
f - asL molecules 
/ # of SPIONs 
7.36 μg 
SPION:faSL 798 35.6 0.0001071 2.14E-08 1.29E+16 4.30
3.68 μg 
SPION:faSL  332 16.5 4.955E-05 9.91E-09 5.97E+15 2.11
1.84 μg 
SPION:faSL 141 8.6 2.596E-05 5.19E-09 3.13E+15 1.11
0.92 μg 
SPION:faSL 50 4.9 1.473E-05 2.95E-09 1.77E+15 0.63
 
Molecular weight of fluorescein = 332.31 g/mol 





3.4 Conclusions & future directions 
SPIONs were surface modified with a biocompatible polymer: octylamine 
modified polyacrylic acid. Aqueous solutions of surface modified SPIONs are 
amenable to moderate scale-up due to the simple synthesis. An anticancer drug 
Epirubicin is loaded efficiently and quantified by visible absorbance 
measurement. However, the bioavailability of the drug released from SPIONs 
should be further studied by in vitro drug release studies. The presence of 
functional groups on the polymer made the coupling of DNA possible. The 
coupling of antisense survivin DNA to PAA-OA-SPIONs using EDC-coupling 
successful and was verified by spectroscopic techniques. The coupling of 
oligonucleotide survivin to modified SPIONs will likely lead to active targeting of 
drug loaden SPIONs selectively to cancer cells. This targeting mechanism is 
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Nanoparticles are widely being used in various fields such as drug delivery, 
imaging, labeling, sensing, analytical and bio-separations.1-3 Surface modification 
of nanoparticles facilitates conjugation of biomolecules.4-6 Recently, 
nanoparticles are being conjugated to aptamers.7 In chapter 2 and 3, I used 
surface modified magnetic nanoparticles for biological applications. Here in this 
chapter, I will demonstrate the use of magnetic nanoparticles for analytical 
applications. SPIONs are used for immobilizing aptamers via biotin-avidin 
chemistry and used as capture tools for steroids in the present work. 
 
Aptamers (also known as molecular recognition elements) are developed by an 
in vitro selection process called SELEX.8 SELEX (Systematic Evolution of 
Ligands by Exponential Enrichment) is a process wherein the DNA/RNA ligands 
are generated from a random pool of modified or unmodified DNA or RNA. The 
ligands selected through this process are called aptamers (single stranded 
synthetic DNA or RNA capable of folding into unique 3D structures). Aptamers 
are widely being used as molecular recognition elements in the fields of 
biosensing, diagnostics and therapeutics.9-13 Previously, antibodies were coupled 
to nanoparticles for using them in bio-applications.14, 15 However, aptamers 
posses additional advantages such as low molecular weights, easy and 
reproducible synthesis, low toxicity and high binding affinity and selectivity. The 
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ability of aptamers to distinguish targets from subtle structural differences and 
bind any target with high affinity made them unique tools in bio-analytical 
applications.9, 16 
 
There is an increasing use of aptamers in biosensors for the detection of small 
molecules.17-19 Kim et al. discovered a 76 mer DNA aptamer selective to 17β-
estradiol (E2).20 The chemical structure of 17β-estradiol is shown in figure 4.1. 
This aptamer has been proved to have high affinity to estradiol with a 
dissociation constant (Kd) of 0.13 µM by electrochemical method. Gioi et al. used 
aptamer anchored glass microbeads to preconcentrate estradiol in spiked water 
samples and separate bound and unbound fractions using HPLC.21 They 
reported a dissociation constant of 35 µM.  
 
In our group, we used 76mer-DNA aptamer to assess its binding affinity with 
estradiol using stacking enhanced capillary electrophoresis previously developed 
for steroids separation.22 We used streptavidin coated magnetic micro beads as 
the capture elements to separate the bound estradiol from the unbound fraction. 
In the present work, streptavidin coated magnetic nanoparticles are used as the 
capture elements and the separation of bound fraction from the unbound fraction 
of estradiol is carried out in a micro capillary. Specific binding conditions (solvent, 
ionic strength, pH) used is similar to previous work.23  Samples are analyzed on 
capillary electrophoresis (CE) to quantify the bound fraction of estradiol. 
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Capillary electrophoresis is an effective microscale separation method. UV-
visible absorbance is most commonly used for detection but generally has poor 
limit of detection. Stacking and sweeping techniques are used to improve the 
detection limits.24 In the present work, pH-mediated stacking method is used for 
quantification of estradiol captured by the aptamer.  
 
Use of magnetic nanoparticles and in-capillary separation under strong magnetic 



















4.1.1Theory of Capillary electrophoresis 
Electrophoresis is migration of ions in solution under the influence of electric 
field. When a charged molecule (q) is placed in a constant electric field E, it 
experiences an accelerating force qE and a retarding frictional force fu, where u 
is velocity of the ion and f is friction coefficient. 
 
(Accelerated force) qE = fu (frictional force)…………………………… Equation 4.1 
U = q/f E =  µep E..................................................................................Equation 4.2 
 
Where µep is electrophoretic mobility. It is a proportionality constant between 
velocity of ion and electric field strength. 
 
 
Figure 4-2: Charged molecule placed in a constant electric field experiencing 





In capillary electrophoresis (CE), sample is injected into a fused silica (SiO2) 
capillary filled with running buffer and high voltage is applied to separate the 
components. All the solutes migrate with different mobilities and separation occur 
based on size to charge ratio. Electrophoretic mobility and electro-osmotic flow 
dictates the separation in CE. A block diagram of capillary electrophoresis is 














At pH above ~ 2.5, the silanol groups in the capillary are deprotonated and 
posses negative charge. This attracts the cations in the solution to the negative 
surface to partially neutralize the charge. This forms an electric double layer at 
the capillary wall. Electroosmotic flow (µos) is a uniform plug like flow of solute 
molecules towards cathode driven by the cations in diffuse double layer in the 











Electrophoretic mobility (µep) is the migration of charged ions under the influence 
of applied electric field. It is directly proportional to the charge on the ion (q) and 
inversely proportional to the frictional coefficient (f). A pictorial representation of 
electrophoretic mobility is shown in figure 4-5. The apparent or observed mobility 
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of the analytes is the sum of electro-osmotic flow and electrophoretic mobility 
given by equation 4.3. 
 
Apparent mobility (µapp) = µep + µos……………………………………….Equation 4.3 
 
The movement of analytes due to applied voltage from anode to cathode is 












4.1.2 Advantages of CE 
Capillary electrophoresis is a well known separation technique which offers 
several advantages.25, 26 There is no stationary phase in CE and the flow of 
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sample in the open capillary tube is a plug flow as opposed to hydrodynamic flow 
in a chromatographic column. This eliminates the longitudinal diffusion and mass 
transfer mechanisms involved in the chromatographic separations. Hence, CE 
provides high efficiency and resolution. Since CE uses micron size capillaries, it 
requires extremely small sample volumes (as low as microliters to nanoliters). 
The processing time of samples is faster than other separation techniques like 
chromatography. CE can be used for separation and analysis of a wide range of 
analytes both charged as well as neutral. It is especially a useful tool for 
analyzing biomolecules such as proteins and nucleic acids.27-29 
 
 
4.1.3 Micellar electrokinetic chromatography (MEKC) 
Micellar electrokinetic chromatography (MEKC) is a type of CE which includes a 
pseudo stationary phase of micelles. It offers many advantages over capillary 
zone electrophoresis.30 MEKC separates neutral molecules and ions. Surface 
active agents or surfactants form micelles above their critical micellar 
concentrations. Surfactants can be anionic, cationic, zwitterionic and neutral. Any 
of these types or a combination can be used as pseudo stationary phase in 
MEKC. Sodium dodecyl sulfate (SDS), an anionic surfactant, is extensively used 
in MEKC. The electrophoretic mobility of negatively charged micelles is from 
cathode to anode while the electro-osmotic flow is from anode to cathode. The 
apparent mobility of the micelles is towards cathode as EOF is dominant. The 
migration time of neutral analytes depends on their partitioning between the 
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micelles. Cyclodextrins (CD) are neutral, inert and stable cyclic oligomers of α-D-
glucose with a hollow cavity. They are widely used for separation of optical 
isomers and enantiomers.31-33 The interior of cyclodextrin is non-polar and hence 
accommodates hydrophobic neutral analytes while the exterior is polar making it 
soluble in water. Cyclodextrins move along with EOF as they are neutral. These 




















The basic instrumentation of capillary electrophoresis includes a micron size 
fused silica capillary with the two ends placed in buffer reservoirs containing 
platinum electrodes. The sample is injected into the capillary either 
hydrodynamically by applying pressure or electrokinetically by applying voltage 
on injection side. In normal polarity, sample is injected from anode to cathode. In 
reverse polarity, sample is injected from cathode to anode. The detector is 
placed on the outlet side of the capillary. Most of the instruments commonly have 
UV-Visible detector. However, fluorescence and electrochemical detectors can 
also be used on CE. The photographs of CE instrumentation are shown in figure 


















Figure 4-7. Photographs of the Beckman® automated capillary electrophoresis 
machine used in the work. The light source is a UV-visible absorbance, with a 
PMT or PDA detector. 
 
  











4.2 Materials and methods 
4.2.1 Reagents and materials  
The biotinylated DNA aptamer was synthesized by IDT (Coralville, IO, USA). 
Sodium hydroxide, sodium chloride, potassium chloride, sodium dodecyl sulfate 
(SDS), carboxymethyl-β-cyclodextrin, testosterone, and 3-[cyclohexylamino]-1-
propanesulfonic acid (CAPS) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Streptavidin modified superparamagnetic iron oxide nanoparticles 
(SHS30) were purchased from Ocean Nanotech (Springdale, AR, USA). 
Methanol was purchased from EMD Biosciences (La Jolla, CA, USA). 17β-
estradiol and estrone were purchased from Steraloids, Inc. (Newport, RI, USA). 
17α-ethynyl estradiol was purchased from Cayman Chemical (Ann Arbor, MI, 
USA). Hydroxypropyl-β-cyclodextrin (HPCD) was purchased from VWR (West 
Chester, PA, USA). Hydrochloric acid, magnesium chloride, and sodium 
phosphate monobasic salt were purchased from Fisher Scientific (Fair Lawn, NJ, 
USA). Tris hydrochloride was purchased from Mallinckrodt Maker Inc. 
(Phillipsburg, NJ, USA). Neodymium block magnet BX8X8X8-N52 (1 1/2" x 1 1/2" 
x 1 1/2" thick) used for separation of SPIONs was purchased from K & J 
magnetics, inc. (Jamison, PA, USA). Deionized water was obtained from an Elga 
Purelab ultra water system (Lowell, MA). 
 
4.2.2 Instrumentation 
Separations were performed using a Beckman Coulter P/ACE MDQ capillary 
electrophoresis instrument (Beckman Coulter, Fullerton, CA, USA) shown in 
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Figure 4-7. The P/ACE MDQ was equipped with a photodiode array (PDA) for 
UV-visible absorbance detection which provided simultaneous determination of 
steroids at multiple wavelengths of 200, 225, 254 nm. An Oven was used in 
sample preparation for incubation for biotin-streptavidin release. Centrifugation 
was performed on a picofuge (Stratagene, La Jolla, CA, USA). A vacuum 
centrifuge (Savant, NY, USA) is used for the drying of 10% ethanol solution in the 
sample preparation. The Thermo Scientific Nanodrop 1000 is used to determine 
DNA concentration in the samples. 
 
4.2.3 DNA aptamer 
The DNA aptamer (GCT TCC AGC TTA TTG AAT TAC ACG CAG AGG GTA 
GCG GCT CTG CGC ATT CAA TTG CTG CGC GCT GAA GCG CGG AAG C) 
was synthesized with a biotin connected to the 5’ base via a 15 atom spacer arm 
(tetra-ethyleneglycol). The aptamer was reconstituted at a concentration of 10 
μM in a binding buffer similar to that previously reported (200 mM NaCl, 10 mM 
MgCl2, 25 mM, KCl, 5% ethanol, 100 mM Tris-HCl buffered at pH 8) .
20 
 
4.2.4 Capillary Electrophoresis separation conditions 
30 cm long fused-silica capillary with an inner diameter of 25 um and outer 
diameter of 360 um (Polymicro Technologies, LLC, Phoenix, AZ, USA) is used 
for separations. The detection window was placed at 10.2 cm from the site of 
injection. The capillary is maintained at 25 ºC during all the flushes and runs. The 
separation buffer used comprised of 30 mM SDS, 13 mM hydroxypropyl-β-
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cyclodextrin, 200 mM phosphate buffered at pH 2.5. Reverse polarity at 16 kV is 
used for separation (cathode at the point of injection and anode at the outlet). 
 
4.2.5 Binding experiment 
The biotinylated aptamer is coupled to 30 nm size streptavidin coated SPIONs. In 
this experiment, 50 µL of SPIONs with a concentration of 1 mg/mL is taken. An 
approximate binding capacity of 850 picomoles of single-stranded oligonucleotide 
per mg nanoparticles was reported by the manufacturer. Approximately 50 µL of 
SPIONs can bind to 40 picomoles of biotinylated DNA. 50 µL SPIONs was 
passed through magnet and reconstituted in 20 µL of binding buffer. Therefore, 
the DNA binding concentration of SPIONs is 2 µM (40 picomoles). 
 
The aptamer is denatured at 90 ºC for 10 mins in binding buffer and cooled to 
room temperature (shown in figure 4-8). The estradiol is added to denatured 
DNA at the specified concentration and incubated for 1 hr at 25 ºC. A sample of 
SPIONs is taken into a microcapillary by capillary action and held in a high 
magnetic field (on the edge of a strong magnet) for about 20 min. The glass 
microcapillary used in this procedure can hold 100 µL volumes. It is 
approximately 11.5 cm long and 340 µm in diameter. During the waiting period 
SPIONs settle down on the sidewall and the supernatant is eluted using a rubber 
bulb with a 10-100 µL plastic pipette tip. Low quality SPIONs having differences 
in size and magnetic nature are discarded in the supernatant. SPIONs were then 
reconstituted deionised water. Later the aptamer-estradiol complex is added to 
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washed SPIONs and incubated for 30 mins. After incubation, solution is filled in a 
microcapillary and held in a high magnetic field about 20 min. The unbound DNA 
and estradiol is washed off the SPIONs by reconstituting with binding buffer, 
placing on the magnet and eluting the supernatant. This removes any residual 
DNA or estradiol. The washing procedure is shown in figure 4-9. The washed 
SPIONs are reconstituted in 10% ethanol. To release the DNA bound to the 
SPIONs, they are heated at 70 ºC for 10 min. Heating at this temperature 
reportedly dissociates biotin-streptavidin interaction.34 The solution is cooled to 
room temperature and pulled into micro capillary which is placed on the edge of 
the magnet. The SPIONs are held in place by the magnet; the solution is eluted 
into a vial, and dried in a vacuum centrifuge. The dried estradiol is then 
reconstituted by stack buffer comprised of 1mM carboxymethyl-β-cyclodextrin 
and 100 mM CAPS buffered at pH 10. The sample is then injected into 
separation capillary using the sample stacking method previously reported.22 This 
stacking mechanism is proved to increase the steroid concentration by 10 fold. 
The schematic of the experimental procedure is represented in figure 4-10. 
 
4.2.6 Separation mechanism 
The running buffer filled in the capillary is 200 mM phosphate buffer at pH 2.5 
comprised of 30 mM SDS and 13 mM HPCD. The stacking buffer used is 1mM 
CMCD in 50 mM CAPS buffered at pH 10 with 5% methanol. Methanol aids in 
solubilization of hydrophobic steroids. The estradiol steroid is electrokinetically 
injected into the capillary by applying 10 kV high voltage at reversed polarity for 
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60 sec. At high pH of the stacking buffer, CMCDs are deprotonated and carry the 
neutral steroids. As the sample in stacking buffer is injected, it forms a pH 
junction in the capillary concentrating the neutral steroid-CMCD complex. 
Electro-osmotic flow is insignificant in the capillary which slows down the 
movement of neutral molecules such as HPCD. Electrophoretic mobility helps in 
the movement of negatively charged SDS molecules. The steroids partition 
between negatively charged SDS and CMCDs and are separated at 16kV under 

















Figure 4-8: Denaturing of DNA aptamer and its renaturing at room temperature 
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Figure 4-10: Schematic of binding affinity study of 76mer with estradiol using 
SPIONs as capture elements 
 
Low quality SPIONs from 
the stock were discarded 
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Figure 4-11: Schematic of pH mediated micellar electrokinetic chromatography 
(MEKC) stacking of estradiol. Separation buffer used was pH 2.5 phosphate 
buffer containing sodium dodecyl sulfate (SDS) and Hydroxypropyl cyclodextrin 
(HPCD). Stack buffer used is pH 10 CAPS buffer containing Carboxymethyl 
































4.3 Results and discussion 
4.3.1 Aptamer binding 
Aptamer immobilized on SPIONs is incubated with concentrations of estradiol 
ranging from 18 µM to 95 µM to determine the binding affinity. The unbound 
estradiol is removed by washing with the binding buffer. Binding buffer is used to 
maintain the right confirmation of aptamer. The estradiol bound to the aptamer on 
SPIONs is released into 10% ethanol by heating at 70 ºC. This solution is dried in 
the vacuum centrifuge. It is then reconstituted in stack buffer and quantified by 
sample stacking and capillary electrophoresis. This process of drying and 
reconstituting ensures the volumes of the samples is the same and there is no 
loss of estradiol during elution step. Standard addition is used to quantify the 
estradiol binding in each sample. 
 
4.3.2 Standard addition method 
In standard addition, known concentration of estradiol is added to each sample. 
The amount of unknown estradiol is deduced from the increase in analytical 
signal. The response to increasing concentrations of added known estradiol 
produced a linear response. Since the sample preparation involves use of 
nanoparticles and multiple washing steps with high salt containing buffer, the 
matrix affects the analytical signal. Hence, standard addition method is more 
appropriate to these samples. The assumption is that the matrix effect is same 
on added estradiol as it has on the original estradiol concentration in the 
unknown. 
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4.3.3 DNA determination 
The DNA concentration in each sample is determined using Thermo Scientific 
Nanodrop 1000 using stacking buffer spiked with steroid as the blank. Nanodrop 
1000 is a UV-vis spectrophotometer which can provide full spectrum data (200-
800 μm). It has a compact design and uses very small volumes of samples (0.5 – 
2.0 μL). It is especially used for nucleic acid or protein concentration 
measurements. Though the DNA concentration introduced initially in each 
sample is the same, the concentration varies during the sample preparation due 
to loss of nanoparticles in washes. So, the DNA recovered from each sample is 
normalized by dividing the concentration in a single set by lowest concentration 
of DNA within the set. The bound estradiol is then divided by this factor. 
Assuming the relative losses of DNA on all the samples is same, concentration is 
normalized based on lowest DNA concentration. 
 
4.3.4 Plotting data 
The specific binding curve is obtained by plotting normalized estradiol bound to 
DNA against free estradiol used initially. The data was fit on GraphPad Prism 
version 4 using one-site binding model described by the equation, Y= ((Bmax * X)/ 
(Kd + X)) + NS* X , where Bmax is the maximal binding and Kd is the dissociation 





4.3.5 Non-specific binding 
The non specific binding curve is done using a 37 base reverse E2 primer ( 5’-
GCT TCC GCG CTT CAG CGC -3’) of the aptamer. The added reverse 
compliment couples to part of the estradiol aptamer with 76 bases. So, the 
aptamer is not in the right configuration and the estradiol binding to this complex 
is considered as non-specific binding. Non-specific binding also includes the 
estradiol binding to the surface of nanoparticles as well. The value of non-specific 
binding was estimated using slope of the curve 0.0013.  
 
Nonlinear regression analysis of the binding curve gave a dissociation constant 
of Kd = 11 ± 4 μM and Bmax = 0.43 ± 0.03 μM with an R
2= 0.908. The binding 
curves are repeated three times to ensure the reproducibility of the results. The 
results are shown in the table 4-2 with Kd and Bmax values. The binding curves 
are shown in figure 4-13. 
 
4.3.6 “Magnetic micro particles” Vs “magnetic nanoparticles” 
Previously, the binding affinity of the 76 mer aptamer to estradiol is determined 
using magnetic microbeads with streptavidin surface to aid the immobilization of 
aptamer.23 The size of the microbeads used in our previous work is 1um 
(1000nm). An approximate binding capacity of 500 picomoles of single stranded 
20 base pair biotinylated oligonucleotide per mg of bead was reported by the 
manufacturer. The volume of beads used was 40 µL (concentration 5 mg/ml). 
Thus, these beads can bind a maximum DNA concentration of ~2 μM (80 
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picomoles). There is no shelf life for these beads. Microbeads are easy to 
concentrate in solution by placing them on magnet due to their larger size. The 
larger size of beads also tends to cause less loss of beads during sample 
preparation steps. The Kd value reported with magnetic microbeads is Kd = 70 ± 
10 μM and a Bmax = 0.42 ± 0.03 μM. 
 
In the present paper, superparamagnetic iron oxide nanoparticles (SPIONs) of 30 
nm size with streptavidin surface are used. The SPIONs purchased have a shelf 
life of three months and noticeably they did not give good results after the 
expiration date. The aptamer is immobilized on streptavidin modified SPION 
surface and the bound and unbound estradiol separation during the sample 
preparation is done in a micro capillary. The smaller size of SPIONs accounts for 
their greater stability in solution and the time required to concentrate them on a 
magnet is much higher compared to microbeads. The loss of nanoparticles 
during the sample preparation is more due to sticking of SPIONs to glass micro 
capillary and the eppendrof tubes used for reconstitution of samples. 
 
From the experimental results obtained with SPIONs, Kd = 11 ± 4 μM and Bmax = 
0.43 ± 0.03 μM. It is shown that the binding affinity constant Kd of the aptamer is 
approximately 8 times lesser than that obtained using the magnetic micro beads 
which tells that the binding of estradiol to aptamer immobilized on SPIONs is 
occurring at a higher rate. This can be explained by the higher surface area of 
the nanoparticles and compact packing of biotinylated aptamer on the 
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streptavidin coated nanoparticles. The comparison of Kd and Bmax obtained from 






Table 4-1: Comparison of Kd and Bmax values obtained from the aptamer binding 









SPIONs 11 ± 4 μM 0.43 ± 0.03 μM 0.0013 













Figure 4-12: Representative electropherogram showing a single standard 
addition determination. DNA in the sample is separated from estradiol and is 
represented by the peak at 1.75 min. Inset shows the traces of bound estradiol. 
The known concentrations of estradiol added to the sample gave a linear 











Figure 4-13: Represents three determinations of binding affinity of 76mer 
aptamer and steroids using SPIONs as capture elements. The ratio of bound 
estradiol to total DNA is plotted on the y-axis and initial free concentration of 
estradiol is plotted on x-axis. The equation used to fit non-linear data is Y= ((Bmax 
* X)/ (Kd + X)) + NS* X, where Bmax is the maximal binding and Kd is the 











Table 4-2: Raw Data Used for each Binding Isotherm 




18 0.65 0.36 0.06 17.64 0.29 
30 0.81 0.56 0.06 29.44 0.37 
48 1.18 0.81 0.08 47.19 0.37 
65 0.54 0.49 0.05 64.51 0.49 
83 0.83 0.74 0.08 82.26 0.48 
95 0.58 0.56 0.07 94.44 0.52 
Kd = 11 ± 4 R
2 = 0.908    
     Bmax = 0.43 ± 0.03 
 
Set 2 
18 0.57 0.19 0.04 17.81 0.19 
30 1.05 0.42 0.03 29.58 0.23 
48 0.78 0.42 0.05 47.58 0.31 
83 0.79 0.46 0.03 82.54 0.34 
95 0.95 0.57 0.06 94.43 0.34 
Kd = 9 ± 4 R
2 = 0.941    
    Bmax = 0.26 ± 0.02     
 
Set 3 
18 0.75 0.24 0.02 17.76 0.21 
30 1.41 0.61 0.03 29.39 0.29 
48 0.77 0.43 0.04 47.57 0.37 
65 0.66 0.38 0.02 64.62 0.38 
95 1.24 0.72 0.05 94.28 0.38 
Kd = 10 ± 6 R
2 = 0.847    
    Bmax = 0.32 ± 0.04 







4.4 Conclusions and future directions 
We have developed an effective method of capturing estradiol using aptamer 
anchored magnetic nanoparticles. SPIONs are proven to be effective platform for 
analytical sensing. Furthermore, this method can be extended to other small 
molecules for which aptamers have been developed. Using different aptamers, 
multiple compounds can be separated. This will help in detecting multiple 
compounds in a variety of samples using micro scale devices. SPIONs could be 
easier to incorporate in micro or nano scale biosensors. This work can be 
considered as a preliminary study to show that the magnetic nanoparticles can 
be more effective separation tools compared to microbeads. Further studies on 
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